المساهمون: and Jerry, D

وصف الملف: Medium: ED; Size: 3 pages

الوصول الحر: http://www.osti.gov/scitech/servlets/purl/1039284Test

المؤلفون: Zhang, Yu, Lee, John, Toso, Erik, Lee, Joslynn, Choi, Si, Slattery, Matthew, Aihara, Hideki, Kyba, Michael

مصطلحات موضوعية: DUX4, Facioscapulohumeral muscular dystrophy, FSHD, SELEX

العلاقة: http://www.skeletalmusclejournal.com/content/6/1/8Test

الإتاحة: http://www.skeletalmusclejournal.com/content/6/1/8Test

المؤلفون: Veenhuizen, Yvonne, Cup, Edith, Groothuis, Jan T, Hendriks, Jan, Adang, Eddy, van Engelen, Baziel, Geurts, Alexander

مصطلحات موضوعية: Neuromuscular disease, Facioscapulohumeral muscular dystrophy (FSHD), Inclusion body myositis (IBM), Mitochondrial myopathy, Self-management, Participation, Effectiveness, Randomized controlled trial, Study protocol, Energy conservation

العلاقة: http://www.biomedcentral.com/1471-2377/15/58Test

الإتاحة: http://www.biomedcentral.com/1471-2377/15/58Test

المؤلفون: Harafuji, Naoe, Schneiderat, Peter, Walter, Maggie C, Chen, Yi-Wen

مصطلحات موضوعية: FSHD, microRNA, miR-411, YAF2, YY1, Myod, myogenin

العلاقة: http://www.ojrd.com/content/8/1/55Test

الإتاحة: http://www.ojrd.com/content/8/1/55Test

المصدر: New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography.

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05902884Test

المصدر: A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Adult Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05747924Test

Other URLs: https://www.aviditybiosciences.comTest/
https://fortitude-study.comTest/

المصدر: A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Pharmacodynamics, Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05548556Test

المؤلفون: Richard M. Schulze Family Foundation

المصدر: Schulze Muscular Dystrophy Ability Clinical Study

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05409079Test

المصدر: Barbour AM, Sarov-Blat L, CaG, Fossler MJ, Sprecher DL, Graggaber J, McGeoch AT, Maon J, Cheran J. Safety, toleraby, pharmacokets and pharmacodynams of losmapod followg a sgle travenous or oral dose healthy volunteers. Br J Cl Pharmacol. 2013 Jul;76(1):99-106. do 10.1111/bcp.12063.
Han JJ, Kurlo G, Abresch RT, de B E, NorA, Bajcsy R. Reachable workspace facscapulohumeral muscular dystrophy (FSHD) by Kect. Muscle Nerve. 2015 Feb;51(2):168-75. do 10.1002/mus.24287. Epub 2014 Nov 19.
Melln ML, Ronco L, Berends CL, Pagan L, Brooks S, van Esdonk MJ, van Brummelen EMJ, Odueyungbo A, Thompson LA, Hage M, Badrg UA, Raes S, Tracewell WG, van Engelen B, Cadav D, Groeneveld GJ. Phase 1 clal trl of losmapod facscapulohumeral dystrophy: Safety, toleraby, pharmacokets, and target engagement. Br J Cl Pharmacol. 2021 Dec;87(12):4658-4669. do 10.1111/bcp.14884. Epub 2021 May 14.
A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled, 48-Week, Parallel-Group Study of the Efficacy and Safety of Losmapimod in Treating Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05397470Test

المساهمون: Prof. Dr. Benedikt Schoser, Professor of Neurology

المصدر: Pompe & Pain - Observational Study to Assess Musculoskeletal Pain in Late-onset Pompe Disease (LOPD)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05272969Test